Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
about
Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cellsBone graft substitutes for spine fusion: A brief reviewCytokine networking of chondrocyte dedifferentiation in vitro and its implications for cell-based cartilage therapyClinical translation of controlled protein delivery systems for tissue engineeringThe use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applicationsLessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?A consensus statement regarding the utilization of BMP in spine surgeryA review of the current published spinal literature regarding bone morphogenetic protein-2: an insight into potential biasThe controversy surrounding bone morphogenetic proteins in the spine: a review of current researchA meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graftReporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusionLong-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates.Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing.Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up.Maxillary sinus floor elevation using a tissue-engineered bone complex with beta-TCP and BMP-2 gene-modified bMSCs in rabbits.Development and optimization of a cell-based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein-2 activity.Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffoldSelective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradationFormulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.The effect of electroacupuncture on the extracellular matrix synthesis and degradation in a rabbit model of disc degenerationTGF-β1 as possible link between loss of bone mineral density and chronic inflammation.Material properties and osteogenic differentiation of marrow stromal cells on fiber-reinforced laminated hydrogel nanocompositesHeterotopic ossification related to the use of recombinant human BMP-2 in osteonecrosis of femoral headClinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up studyThe use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis.An economic analysis of using rhBMP-2 for lumbar fusion in Germany, France and UK from a societal perspective.Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation.BMP-2 and TGF-β3 do not prevent spontaneous degeneration in rabbit disc explants but induce ossification of the annulus fibrosusRemodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads.The effect of poloxamer 407-based hydrogel on the osteoinductivity of demineralized bone matrixPreconditioning Human Mesenchymal Stem Cells with a Low Concentration of BMP2 Stimulates Proliferation and Osteogenic Differentiation In Vitro.Nell-1 protein promotes bone formation in a sheep spinal fusion model.Heterodimeric BMP-2/7 antagonizes the inhibition of all-trans retinoic acid and promotes the osteoblastogenesis.Coordinated regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by endogenous bone morphogenetic proteins.Bone tissue engineering: recent advances and promising therapeutic agents.Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials.Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges.
P2860
Q24306652-AFF51D40-A920-439A-A28C-15AED321BCF2Q26801875-1A8E0F75-B4B7-44D4-B26C-A349A20DE7B3Q26998702-3B3E09C3-0B60-4753-90DB-402D92637F04Q28084738-D333AB74-8A41-4A4B-B67F-7461FA0B3A6BQ28262713-C0F0788E-3509-492A-8A1B-990B61D74858Q28606705-0BC333F7-6F20-44B7-8AB7-17D77998000AQ28606708-1DE671E6-B36F-497B-980B-C30A53E0F60AQ28606711-887FB95F-37DD-4015-BB3C-968681E3E41AQ28650307-1A07EF25-8BCB-4905-9CFE-BA2BF5974861Q28658928-74AA37AF-3BD0-45A7-AD5C-0FC87E79BE63Q28681258-21D91E7D-4CD3-4EA9-8440-3FC52EC3F2BDQ30277865-A87CBD5D-BD48-4CFF-B400-31CDDEE6035DQ30432348-57388EEC-4501-4D86-A650-C904CB7264E1Q30452980-DBF46FC8-195C-42FC-9281-B753B4A6AD10Q33496943-B686786A-7485-45B9-BC58-F050B3EBB826Q33513238-42B88195-25EB-4DD8-BC6C-33E988CBB4E7Q33530159-A47565B4-AFCE-4A93-900F-7BA7B4D749D8Q33614939-89CC1B61-A435-4347-B841-A09E6946595AQ33639409-71741BB1-79E1-4A91-B0EA-47342DF31C05Q33716899-BBB62F9C-3FB8-4B29-A581-950B7B4CE5D7Q33758662-23E9FFBF-8452-4A43-95EA-A8355DE48D3EQ33761160-F8E32CF7-684B-4F28-B325-9B8F1FD8F135Q33823505-041B3805-6990-475C-80F0-2CB66AF6C9C3Q33885851-0976DB1A-7933-4E91-8594-D15CBCF9B53CQ33969749-2DF4FB2F-8D3A-4428-AED4-68E28B6DADC9Q33972090-EC90DE52-A54E-4CD8-8FDB-BD6AA6092B2EQ33973336-0D63049C-B1A6-4FC3-9397-39A1B24C3885Q33990177-A1185AA1-5D71-48E3-842C-D7F1D5851CB3Q34145493-01169367-F692-4EAC-B739-F35265833714Q34283962-649F7F98-BFC4-4481-BF95-EE49F74A2364Q34345061-68E65EE6-7189-4DF6-8D8B-5CBCB326DFDAQ34513270-1DCFF122-E7E4-4D3C-B6D4-04B461D0DCD6Q34518854-0CB10E06-C557-4EF0-927A-3D918945C82DQ34579496-DFD45322-3A29-45E8-A687-B8B5AA351B03Q34715389-E59D6094-62AD-45D7-8D24-96ADE7CF1486Q35036192-5B2DD16E-29C1-4A38-90C8-69981BEB0336Q35108879-178D463C-B534-4EE4-A890-B69A1C31C0B0Q35144021-BE7BA084-A941-4E04-8342-FBC33A75C65EQ35165694-864D40B5-562E-40FB-8ECD-93276F4C870FQ35199301-A83E2A70-7DCE-4114-AB92-D39111915BC9
P2860
Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of recombinant human bone ...... lvo Award in clinical studies.
@en
Use of recombinant human bone ...... lvo Award in clinical studies.
@nl
type
label
Use of recombinant human bone ...... lvo Award in clinical studies.
@en
Use of recombinant human bone ...... lvo Award in clinical studies.
@nl
prefLabel
Use of recombinant human bone ...... lvo Award in clinical studies.
@en
Use of recombinant human bone ...... lvo Award in clinical studies.
@nl
P2093
P1433
P1476
Use of recombinant human bone ...... lvo Award in clinical studies.
@en
P2093
Harvinder Sandhu
James Kang
John G Heller
Scott D Boden
P304
P356
10.1097/00007632-200212010-00005
P407
P577
2002-12-01T00:00:00Z